These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29031955)

  • 1. Determination of Nonspherical Morphology of Doxorubicin-Loaded Liposomes by Atomic Force Microscopy.
    Takahashi N; Higashi K; Ueda K; Yamamoto K; Moribe K
    J Pharm Sci; 2018 Feb; 107(2):717-726. PubMed ID: 29031955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple and rapid measurement method of encapsulation efficiency of doxorubicin loaded liposomes by direct injection of the liposomal suspension to liquid chromatography.
    Yamamoto E; Miyazaki S; Aoyama C; Kato M
    Int J Pharm; 2018 Jan; 536(1):21-28. PubMed ID: 29175642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practical aspects in size and morphology characterization of drug-loaded nano-liposomes.
    Peretz Damari S; Shamrakov D; Varenik M; Koren E; Nativ-Roth E; Barenholz Y; Regev O
    Int J Pharm; 2018 Aug; 547(1-2):648-655. PubMed ID: 29913218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Size Determination of a Liposomal Drug by Small-Angle X-ray Scattering Using Continuous Contrast Variation.
    Garcia-Diez R; Gollwitzer C; Krumrey M; Varga Z
    Langmuir; 2016 Jan; 32(3):772-8. PubMed ID: 26673729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Doxorubicin physical state in solution and inside liposomes loaded via a pH gradient.
    Li X; Hirsh DJ; Cabral-Lilly D; Zirkel A; Gruner SM; Janoff AS; Perkins WR
    Biochim Biophys Acta; 1998 Dec; 1415(1):23-40. PubMed ID: 9858673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and characterisation of liposomal doxorubicin with loaded gold nanoparticles.
    Karimi Zarchi AA; Amini SM; Salimi A; Kharazi S
    IET Nanobiotechnol; 2018 Sep; 12(6):846-849. PubMed ID: 30104461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a Flow-Through USP-4 Apparatus Drug Release Assay to Evaluate Doxorubicin Liposomes.
    Yuan W; Kuai R; Dai Z; Yuan Y; Zheng N; Jiang W; Noble C; Hayes M; Szoka FC; Schwendeman A
    AAPS J; 2017 Jan; 19(1):150-160. PubMed ID: 27485642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenium-functionalized liposomes for systemic delivery of doxorubicin with enhanced pharmacokinetics and anticancer effect.
    Xie Q; Deng W; Yuan X; Wang H; Ma Z; Wu B; Zhang X
    Eur J Pharm Biopharm; 2018 Jan; 122():87-95. PubMed ID: 29032193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of doxorubicin liposomal formulations for size-based distribution of drug and excipients using asymmetric-flow field-flow fractionation (AF4) and liquid chromatography-mass spectrometry (LC-MS).
    Ansar SM; Mudalige T
    Int J Pharm; 2020 Jan; 574():118906. PubMed ID: 31805309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doxorubicin-loaded nanocarriers: A comparative study of liposome and nanostructured lipid carrier as alternatives for cancer therapy.
    Fernandes RS; Silva JO; Monteiro LOF; Leite EA; Cassali GD; Rubello D; Cardoso VN; Ferreira LAM; Oliveira MC; de Barros ALB
    Biomed Pharmacother; 2016 Dec; 84():252-257. PubMed ID: 27664949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhanced Cytotoxicity of Folic Acid-Targeted Liposomes Co-Loaded with C6 Ceramide and Doxorubicin: In Vitro Evaluation on HeLa, A2780-ADR, and H69-AR Cells.
    Sriraman SK; Pan J; Sarisozen C; Luther E; Torchilin V
    Mol Pharm; 2016 Feb; 13(2):428-37. PubMed ID: 26702994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heating treatments affect the thermal behaviour of doxorubicin loaded in PEGylated liposomes.
    Perinelli DR; Cespi M; Bonacucina G; Rendina F; Palmieri GF
    Int J Pharm; 2017 Dec; 534(1-2):81-88. PubMed ID: 28993166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation kit for liposomal doxorubicin composed of lyophilized liposomes.
    Stevens PJ; Lee RJ
    Anticancer Res; 2003; 23(1A):439-42. PubMed ID: 12680245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human Biomolecular Corona of Liposomal Doxorubicin: The Overlooked Factor in Anticancer Drug Delivery.
    Caracciolo G; Palchetti S; Digiacomo L; Chiozzi RZZ; Capriotti AL; Amenitsch H; Tentori PM; Palmieri V; Papi M; Cardarelli F; Pozzi D; Laganà A
    ACS Appl Mater Interfaces; 2018 Jul; 10(27):22951-22962. PubMed ID: 29905462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imaging and size measurement of nanoparticles in aqueous medium by use of atomic force microscopy.
    Takechi-Haraya Y; Goda Y; Sakai-Kato K
    Anal Bioanal Chem; 2018 Feb; 410(5):1525-1531. PubMed ID: 29256078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liposomal nitrooxy-doxorubicin: one step over caelyx in drug-resistant human cancer cells.
    Pedrini I; Gazzano E; Chegaev K; Rolando B; Marengo A; Kopecka J; Fruttero R; Ghigo D; Arpicco S; Riganti C
    Mol Pharm; 2014 Sep; 11(9):3068-79. PubMed ID: 25057799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Engineered peptides for the development of actively tumor targeted liposomal carriers of doxorubicin.
    Shahin M; Soudy R; El-Sikhry H; Seubert JM; Kaur K; Lavasanifar A
    Cancer Lett; 2013 Jul; 334(2):284-92. PubMed ID: 23073474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model.
    Moosavian SA; Abnous K; Badiee A; Jaafari MR
    Colloids Surf B Biointerfaces; 2016 Mar; 139():228-36. PubMed ID: 26722819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive mathematical model of drug release kinetics from nano-liposomes, derived from optimization studies of cationic PEGylated liposomal doxorubicin formulations for drug-gene delivery.
    Haghiralsadat F; Amoabediny G; Helder MN; Naderinezhad S; Sheikhha MH; Forouzanfar T; Zandieh-Doulabi B
    Artif Cells Nanomed Biotechnol; 2018 Feb; 46(1):169-177. PubMed ID: 28376641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation of liposomal doxorubicin-graphene nanosheet and evaluation of its in vitro anti-cancer effects.
    Tajvar S; Mohammadi S; Askari A; Janfaza S; Nikkhah M; Tamjid E; Hosseinkhani S
    J Liposome Res; 2019 Jun; 29(2):163-170. PubMed ID: 30235963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.